<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01556802</url>
  </required_header>
  <id_info>
    <org_study_id>38212050</org_study_id>
    <nct_id>NCT01556802</nct_id>
  </id_info>
  <brief_title>Use of Minocicline in Patients With Stroke</brief_title>
  <official_title>Effect of Minocicline Use in Less Neurologic Sequels in Patients With Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Hernando Moncaleano Perdomo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Hernando Moncaleano Perdomo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will evaluate the National Institute of Health Stroke Scale/Score (NIHSS)in
      patients with stroke, and then give Minocycline 100mg po every 12 hours or placebo for five
      days, then perform periodic evaluations to determine the status and degree of neurological
      sequelae developed.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the efficacy of minocycline in reducing neurological sequelae in patients with stroke</measure>
    <time_frame>one year</time_frame>
    <description>The researchers evaluated the neurological condition of paralysis, aphasia,and level of consciousness by NIHSS score for each patient with stroke and proceeded to give minocycline or placebo. Then, the assessment was repeated after five and thirty days post treatment to determine whether their neurological sequelae had diminushed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify the side effects of the intervention administered during the treatment time and 30 days later.</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">134</enrollment>
  <condition>Stroke</condition>
  <condition>Brain Ischemia</condition>
  <condition>Paralysis</condition>
  <arm_group>
    <arm_group_label>Minocicline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>minocicline 100mg oral twice a day for 5 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pills filled with vegetal fiber with similar presentation of the drug. Given one pill oral twice a day for five days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Minocicline</intervention_name>
    <description>Minocicline 100mg oral twice a day for 5 days</description>
    <arm_group_label>Minocicline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Pills with vegetable fibers one pill oral twice a day for five days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  NIHSS scale greater than 5

          -  Onset of symptoms less than 24 hours

          -  normal Cranial Tomography(CT)

          -  CT evidence of cerebral ischemia

          -  Acceptance of study entry

        Exclusion Criteria:

          -  Hemorrhagic cerebrovascular disease

          -  Other neurological diseases

          -  Concomitant structural damage

          -  History of neurosurgery

          -  Known allergy to tetracyclines

          -  Concomitant infectious diseases requiring antibiotic treatment.

          -  History of Stroke

          -  Women pregnant or breast-feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nataly Bedoya, Internist</last_name>
    <role>Study Director</role>
    <affiliation>Universidad Surcolombiana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hernan Vargas, Internist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Surcolombiana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hugo Osorio, Internist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Surcolombiana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guillermo Gonzalez, Neurologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Surcolombiana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Javier Salda√±a, Epidemiology</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Surcolombiana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Efrain Amaya, Neurologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Hernando Moncaleano Perdomo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nataly Bedoya, md</last_name>
    <email>nata0916@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital hernando Moncaleano Perdomo</name>
      <address>
        <city>Neiva</city>
        <state>Huila</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nataly Bedoya, Md.</last_name>
      <email>nata0916@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2012</study_first_submitted>
  <study_first_submitted_qc>March 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2012</study_first_posted>
  <last_update_submitted>March 15, 2012</last_update_submitted>
  <last_update_submitted_qc>March 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Hernando Moncaleano Perdomo</investigator_affiliation>
    <investigator_full_name>Nataly Bedoya</investigator_full_name>
    <investigator_title>Internist</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>sequelaes</keyword>
  <keyword>minocicline</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

